Abstract
The clinically effective anticancer agents are characterized by their ability to specifically inhibit the synthesis and/or function of DNA (1). Agents that primarily interfere with the synthesis of RNA, protein or other cell constituents lack such antitumor selectivity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bloch A. Purine and Pyrimidine Analoys in Cancer Chemotherapy In: Mihich E (ed) New Leads in Cancer Therapeutics. GK Hall and Co., Boston, 1981, pp 65–72.
Pierce G, Shiles R, Fink L: Cancer, a Problem of Developmental Biology. Prentice Hall, Englewood Cliffs, 1978.
Greaves MP. J Cell Physiol Suppl 1: 113–125, 1982.
Mak TW, McCulloch EA: Cellular and molecular biology of hemopoietic stem cell differentiation. AR Liss, New York, 1982.
Clarkson B, Marks PA, Till JE: Differentiation of normal and neoplastic hematipoietic ceils. Cold Spring Harbor Laboratory, 1978.
Golde DW, Cline MJ, Metcalf D, Fox CF (eds): Hematopoietic Cell Differentiation. Academic Press, New York, 1978.
Schubert D, Jacob F: Proc Nat Acad Sci (USA) (67): 247–254, 1970.
Silbert SW, Goldstein MN: Cancer Res (32): 1422–1427, 1972.
Hozumi M, Honma V, Tomida M, Okabe J, Kasukabe T, Sugiyama K: Acta Haematol Jap (42): 941–962, 1979.
Friedman SJ, Skehan P: Cancer Res (39): 1960–1967, 1979.
Collins SJ, Bodner A, Ting R, Gallo RC: Int J Cancer (25): 213–218, 1980.
Lotem J, Sachs L: Int J Cancer (25): 561–564, 1980.
Papac RJ, Brown AW, Schwartz EL, Sartorelli AC: Cancer Letts (10): 33–38, 1980.
Bodnar AJ, Ting RC, Gallo RC: J Nat Cancer Inst (67): 1025–1030, 1981.
Takeda K, Minowada J, Bloch A: Cancer Res (42): 5152–5158, 1982.
Friend C, Scher W, Holland JG, Sato T: Proc Nat Acad Sci (USA) (68): 378–382, 1971.
Tandka M, Levy J, Terada M, Breslow R, Rifkind RA, Maries PA: Proc Nat Acad Sci (USA) (72):10U3-10UO, 1975.
Collins SJ, Ruscetti Frt, Gallayher KE, Gallo KC: Proc Nat Acad Sci (USA) (75): 2458–2462, 1978.
Rovera G, O’Brien TG, Diamond L: Science (204): 808–870, 1979.
Huberman E, Callaham MF: Proc Nat Acad Sci (76): 1293–1297, 1979.
Lotem J, Sachs L: Proc Nat Acad Sci (USA) (76): 5158–5162, 1979.
Koeffler HP, Bar-Eli M, Territo MC: Cancer Res (41): 919–926, 1981.
Nagasawa K, Mak TW: Proc Nat Acad Sci (USA) (77): 2965, 1980.
LeBien T, Kersey J, Nakazawa S, Minato K, Minowada J: Leukemia Res (6): 299, 1982.
Nakao Y, Matsuda S, Fujita T, Watanabe S, Morikawa S, Saida T, Ito Y: Cancer Res (42): 3843–3850, 1982.
Totterman TH, Nilsson K, Sundstrom C: Nature (288): 176–178, 1980.
Sakagami H, Minowada J, Ozer H, Takeda K, Bloch A: Leukemia Res, in press.
Strickland S, Mahdani V: Cell (15): 393–403, 1978.
Breitman TR, Selonick SE, Collins SJ: Proc Nat Acad Sci (USA) (77): 2936–2940, 1980.
Honma Y, Takenaga K, Kasukabe T, Hozumi M: Biochem Biophys Res Commun (95): 507–512, 1980.
Icnikawa Y: J Cell Physiol (74): 223–234, 1909.
Hozumi MT, Takenaya K, Tornida M, Ukaue J: Gann (39): 5127–5131, 1979.
Metcalf D: J Cell Physiol Suppl i, 175–163, 1862.
Moore MAS: Ibid 53–64, 1962.
Sachs L: Ibid 151–164, 1982.
Takeda K, Minowada J, Leasure JA, Bloch A: Proc Am Assoc Cancer Res (23): 226, 1982.
Craig RW, Frankfurt O, Takeda K, Chheda GB, Bloch A: Proc Am Assoc Cancer Res (24): 15, 1983.
Hayashi M, Okabe J, Hozumi M: Gann (70): 235–238, 1979.
Okabe J, Honma Y, Hayashi M, Hozumi M: Int J Cancer (24): 87–91, 1979.
Baccarani M, Tura S: Br J Haematol (42): 485–490, 1979.
Castaigne S, Daniel MT, Tilly H, Herait P, Degos L: Blood (62): 85–86, 1983.
Takeda K, Minowada J, Bloch A: Cell Immunol (79): 288–297, 1983.
Craig RW, Frankfurt OS, Sakagami H, Bloch A: manuscript in preparation.
Jetten AM: J Cell Physiol (110): 235–240, 1982.
Lee L-S, Weinstein IB: Science (202): 314–315, 1978.
Bloch A: Cancer Treats Repts, in press.
Craig RW, Bloch A: Cancer Research, in press.
Broxmeyer HE, Jacobsen N, Kurland J, Mendelsohn N, Moore MAS: J Nat Cancer Inst (60): 497–510, 1978.
Okabe J, Hayashi M, Honma Y, Hozumi M: Int J Cancer (22): 570–575, 1978.
Editor information
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Bloch, A. (1984). Induction of Cell Differentiation as a Target for Cancer Therapy. In: Harrap, K.R., Davis, W., Calvert, A.H. (eds) Cancer Chemotherapy and Selective Drug Development. Developments in Oncology, vol 23. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3837-6_36
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3837-6_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3839-0
Online ISBN: 978-1-4613-3837-6
eBook Packages: Springer Book Archive